Circulating RAC1 contributed to steroid-sensitive nephrotic syndrome: Mendelian randomization, single-cell RNA-sequencing, proteomic, and experimental evidence DOI Creative Commons
Yi Zhang, Tianwen Yao, Yanqiu Xu

et al.

Renal Failure, Journal Year: 2024, Volume and Issue: 46(2)

Published: Oct. 18, 2024

Objectives The small GTPase Rac1 (RAC1) has been linked to podocyte disorders and steroid-sensitive nephrotic syndrome (SSNS). aim of this study was explore validate the potential causal association between circulating RAC1 SSNS.

Language: Английский

A practical guide for nephrologist peer reviewers: understanding and appraising Mendelian randomization studies DOI Creative Commons
Jianbo Qing, Yafeng Li, Karim Soliman

et al.

Renal Failure, Journal Year: 2025, Volume and Issue: 47(1)

Published: Jan. 13, 2025

Identifying risk factors for disease onset and progression has been a core focus in nephrology research. Mendelian Randomization (MR) emerged as powerful genetic epidemiological approach, utilizing genome-wide association studies (GWAS) to establish causal relationships between modifiable kidney outcomes. MR uses variants instrumental variables infer exposures This method leverages the natural randomization of balance confounders, akin matched cohorts observational The rapid increase on poses challenges journals peer reviewers, especially clinicians unfamiliar with methodology. High-quality use strong, well-validated instruments clear biological relevance, thoroughly testing pleiotropy confounding using methods like MR-Egger. Sensitivity analyses, such MR-PRESSO, should ensure findings remain consistent across various assumptions. Effect sizes confidence intervals be reported discussed within established mechanisms. Additionally, limitations must transparently addressed, recommendations replication future studies, strengthen findings. article guides readers understanding application identifying high-quality helping peers avoid pitfalls while seizing new opportunities advancing

Language: Английский

Citations

7

Identification of Potential Drug Targets for Immunoglobulin A Nephropathy: A Mendelian Randomization Study DOI Creative Commons

Limei Xiong,

Hui Zhang, Yannan Guo

et al.

Biomedicines, Journal Year: 2025, Volume and Issue: 13(3), P. 581 - 581

Published: Feb. 25, 2025

Background: The current pharmacological treatments for Immunoglobulin A nephropathy (IgAN) demonstrate limited effectiveness and may cause serious side effects. This study aimed to explore novel potential drug targets IgAN. Methods: We utilized summarized data from a recent genome-wide association on IgAN, cis-expression quantitative trait loci druggable genes obtained the eQTLGen Consortium, DNA methylation derived GoDMC database. Two-sample Mendelian randomization (MR) analysis, Bayesian colocalization, mediation analysis through two-step MR approach were performed investigate their causal relationships. Results: colocalization analyses demonstrated that expression of HLA-DPA1 C4A was associated with an increased risk In contrast, TUBB, CYP21A2, C4B decreased Mediation revealed acted as mediator in relationship between three sites (cg01140143, cg08898074, cg12168509) mediated proportions 33.74% (95% CI 1.64–73.27), 41.67% 20.78–66.97), 50.34% 27.89–74.76), respectively. Conclusions: Several identified show associations IgAN be targeted development. Nevertheless, additional experimental validation is warranted clarify specific roles pathogenesis

Language: Английский

Citations

0

The Genetics of IgA Nephropathy: Implications for Future Therapies DOI
Shufeng Zhou, Hong Zhang

Seminars in Nephrology, Journal Year: 2025, Volume and Issue: unknown, P. 151567 - 151567

Published: March 1, 2025

Language: Английский

Citations

0

Uncovering leading compounds for alzheimer’s disease treatment: mendelian randomization and virtual screening insights into plasma protein modulation DOI Creative Commons
Xiaohan Sun, Xiaofei Hu, Jianming Wei

et al.

Biological Research, Journal Year: 2025, Volume and Issue: 58(1)

Published: April 5, 2025

Abstract Alzheimer's disease (AD) is a neurodegenerative disorder influenced by both genetic and environmental factors. Identifying therapeutic targets interventions remains challenging. This study utilized Mendelian Randomization (MR) to investigate causal relationships between plasma proteins, lifestyle factors, AD, along with virtual screening identify potential drug compounds. A two-sample MR analysis assessed associations identified through genome-wide association studies (GWAS), AD risk. Co-localization (CA) confirmed the overlap protein expression susceptibility loci, reverse ruled out causality. protein–protein interaction (PPI) network was constructed explore targets, followed small-molecule inhibitors for selected proteins. The found significant eight proteins five (GSTP1, BIN1, Siglec-3, SERPINF2, GRN) showing strong evidence of involvement in pathogenesis. Virtual six compounds as GSTP1 four BIN1. Furthermore, such dietary behaviors smoking cessation, indicated they may influence risk their effects on specific These findings offer novel insights into mechanisms underlying highlight combining targets. also suggests that modifications could alternative prevention treatment strategies AD. Future research should focus experimental validation further linking factors

Language: Английский

Citations

0

Glucagon-like peptide-1 receptor agonists, inflammation, and kidney diseases: evidence from Mendelian randomization DOI Creative Commons
Yuxuan Yao, Chen Tang,

Feng‐Lei Si

et al.

Renal Failure, Journal Year: 2025, Volume and Issue: 47(1)

Published: April 15, 2025

It has been proved that glucagon-like peptide-1 receptor (GLP1R) agonists have positive effects on renal outcomes in diabetic patients. However, it remains unknown whether GLP1R could provide similar protection against other kidney diseases. We performed two-sample Mendelian randomization (MR) analyses to determine the causal of multiple Exposure agonist was proxied by available cis-eQTLs for GLP1R. Primary included risk assessment nephropathy, IgA membranous nephrotic syndrome, chronic disease, acute glomerulonephritis, glomerulonephritis and calculus kidney/ureter. Type 2 diabetes body mass index were used as control. Two-stage network MR conducted assess mediation effect inflammatory proteins relationships between After meta-analyses both discovery validation cohorts, genetically found significantly associated with a decreased nephropathy (OR = 0.72, 95%CI 0.54-0.97, p 0.031) 0.58, 0.36-0.94, 0.027). revealed there an indirect through signaling lymphocytic activation molecule family member 1 (SLAMF1), mediated proportion 34.27% (95% CI, 1.47-67.03%, 0.041) total effect. The findings current study presented genetic proof potential protective development offering novel sight future mechanistic clinical applications.

Language: Английский

Citations

0

Mendelian Randomization Unveils Drug Targets for IgA Nephropathy DOI
Atlas Khan,

Tze Y. Lim,

Simone Sanna‐Cherchi

et al.

Journal of the American Society of Nephrology, Journal Year: 2024, Volume and Issue: 35(8), P. 988 - 991

Published: July 12, 2024

1Division of Nephrology, Department Medicine, Columbia University, New York, York 2Unit Genomic Variability and Complex Diseases, Medical Sciences, University Turin, Italy Correspondence: Dr. Simone Sanna-Cherchi, email: [email protected] See related article, "Circulating Proteins IgA Nephropathy: A Multiancestry Proteome-Wide Mendelian Randomization Study," on pages 1045–1057.

Language: Английский

Citations

1

Circulating RAC1 contributed to steroid-sensitive nephrotic syndrome: Mendelian randomization, single-cell RNA-sequencing, proteomic, and experimental evidence DOI Creative Commons
Yi Zhang, Tianwen Yao, Yanqiu Xu

et al.

Renal Failure, Journal Year: 2024, Volume and Issue: 46(2)

Published: Oct. 18, 2024

Objectives The small GTPase Rac1 (RAC1) has been linked to podocyte disorders and steroid-sensitive nephrotic syndrome (SSNS). aim of this study was explore validate the potential causal association between circulating RAC1 SSNS.

Language: Английский

Citations

0